{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:43:23Z","timestamp":1790052203458,"version":"4.0.1"},"reference-count":202,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.phrs.2024.107168","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T18:58:34Z","timestamp":1712343514000},"page":"107168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["The major histocompatibility complex participates in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"203","author":[{"given":"Rou","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maher Un Nisa","family":"Awan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2024.107168_bib1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson's disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107168_bib2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/mds.27720","article-title":"Environment, lifestyle, and Parkinson's disease: implications for prevention in the next decade","volume":"34","author":"Marras","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.phrs.2024.107168_bib3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12264-019-00433-1","article-title":"Biomarkers for Parkinson's disease: how good are they?","volume":"36","author":"Li","year":"2020","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.phrs.2024.107168_bib4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson's disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.phrs.2024.107168_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117345","article-title":"The benefits and mechanisms of exercise training for Parkinson's disease","volume":"245","author":"Feng","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2024.107168_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson disease epidemiology, pathology, genetics, and pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin. Geriatr. Med"},{"key":"10.1016\/j.phrs.2024.107168_bib7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2024.107168_bib8","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s40520-020-01470-x","article-title":"Parkinson's disease and the non-motor symptoms: hyposmia, weight loss, osteosarcopenia","volume":"32","author":"De Rui","year":"2020","journal-title":"Aging Clin. Exp. Res"},{"key":"10.1016\/j.phrs.2024.107168_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41386-019-0448-y","article-title":"Sleep in Parkinson's disease","volume":"45","author":"Stefani","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2024.107168_bib10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s12264-017-0183-5","article-title":"Biomarkers for Parkinson's disease: recent advancement","volume":"33","author":"Lotankar","year":"2017","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.phrs.2024.107168_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","article-title":"Genetics and Pathogenesis of Parkinson's Syndrome","volume":"18","author":"Ye","year":"2023","journal-title":"Annu Rev. Pathol."},{"key":"10.1016\/j.phrs.2024.107168_bib12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/mds.26421","article-title":"Neuropathology of alpha-synuclein propagation and braak hypothesis","volume":"31","author":"McCann","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.phrs.2024.107168_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/bs.acc.2019.12.001","article-title":"New markers in Parkinson's disease","volume":"96","author":"Bougea","year":"2020","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.phrs.2024.107168_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.phrs.2024.107168_bib15","article-title":"Gut-to-brain alpha-synuclein transmission in Parkinson's disease: evidence for prion-like mechanisms","volume":"24","author":"Chen","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107168_bib16","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1111\/febs.12335","article-title":"The hallmarks of Parkinson's disease","volume":"280","author":"Antony","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.phrs.2024.107168_bib17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jneuroim.2019.01.004","article-title":"Gut microbiota in neurodegenerative disorders","volume":"328","author":"Roy Sarkar","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phrs.2024.107168_bib18","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1136\/gutjnl-2023-329685","article-title":"Gastrointestinal syndromes preceding a diagnosis of Parkinson's disease: testing Braak's hypothesis using a nationwide database for comparison with Alzheimer's disease and cerebrovascular diseases","volume":"72","author":"Konings","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2024.107168_bib19","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41582-022-00681-2","article-title":"The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic","volume":"18","author":"Tan","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2024.107168_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2024.107168_bib21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114402","article-title":"Lysosomal functions and dysfunctions: molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease","volume":"187","author":"Horowitz","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2024.107168_bib23","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tins.2018.11.001","article-title":"Synaptic, mitochondrial, and lysosomal dysfunction in Parkinson's Disease","volume":"42","author":"Nguyen","year":"2019","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.phrs.2024.107168_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41586-023-06866-z","article-title":"A break in mitochondrial endosymbiosis as a basis for inflammatory diseases","volume":"626","author":"Murphy","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107168_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuron.2009.09.015","article-title":"Innate and adaptive autoimmunity directed to the central nervous system","volume":"64","author":"Bhat","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2024.107168_bib26","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1089\/ars.2009.2460","article-title":"Innate and adaptive immunity for the pathobiology of Parkinson's disease","volume":"11","author":"Stone","year":"2009","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.phrs.2024.107168_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9070717","article-title":"Human monocytes plasticity in neurodegeneration","volume":"9","author":"Savinetti","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2024.107168_bib28","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ni.3178","article-title":"Innate immune memory: a paradigm shift in understanding host defense","volume":"16","author":"Netea","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12016-019-08740-1","article-title":"The innate part of the adaptive immune system","volume":"58","author":"Hillion","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib30","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nri3705","article-title":"Innate immune activation in neurodegenerative disease","volume":"14","author":"Heneka","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib31","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1172\/JCI58644","article-title":"Innate immunity in the central nervous system","volume":"122","author":"Ransohoff","year":"2012","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2024.107168_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainres.2014.09.008","article-title":"The role of the immune system in neurodegenerative disorders: adaptive or maladaptive?","volume":"1617","author":"Doty","year":"2015","journal-title":"Brain Res"},{"key":"10.1016\/j.phrs.2024.107168_bib33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/imm.12134","article-title":"Innate and adaptive immune responses in neurodegeneration and repair","volume":"141","author":"Amor","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.phrs.2024.107168_bib34","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3389\/fnins.2019.00916","article-title":"Role of the immune system in the development of the central nervous system","volume":"13","author":"Morimoto","year":"2019","journal-title":"Front Neurosci."},{"key":"10.1016\/j.phrs.2024.107168_bib35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/10738584211024907","article-title":"T Cells: A growing universe of roles in neurodegenerative diseases","volume":"28","author":"Dressman","year":"2022","journal-title":"Neuroscientist"},{"key":"10.1016\/j.phrs.2024.107168_bib36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations (*)","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu Rev. Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib37","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00281-019-00741-8","article-title":"Treg cells in autoimmunity: from identification to Treg-based therapies","volume":"41","author":"Goschl","year":"2019","journal-title":"Semin Immunopathol."},{"key":"10.1016\/j.phrs.2024.107168_bib38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.phrs.2024.107168_bib39","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41583-019-0233-2","article-title":"B cells in autoimmune and neurodegenerative central nervous system diseases","volume":"20","author":"Sabatino","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2024.107168_bib40","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00251-019-01132-x","article-title":"Nomenclature report 2019: major histocompatibility complex genes and alleles of Great and Small Ape and Old and New World monkey species","volume":"72","author":"de Groot","year":"2020","journal-title":"Immunogenetics"},{"key":"10.1016\/j.phrs.2024.107168_bib42","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/iji.12490","article-title":"Comparative genetics of the major histocompatibility complex in humans and nonhuman primates","volume":"47","author":"Heijmans","year":"2020","journal-title":"Int J. Immunogenet."},{"key":"10.1016\/j.phrs.2024.107168_bib43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev-immunol-032414-112334","article-title":"T cell antigen receptor recognition of antigen-presenting molecules","volume":"33","author":"Rossjohn","year":"2015","journal-title":"Annu Rev. Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/imm.12868","article-title":"Soluble major histocompatibility complex molecules in immune regulation: highlighting class II antigens","volume":"153","author":"Bakela","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.phrs.2024.107168_bib45","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fimmu.2017.00292","article-title":"Major histocompatibility complex (MHC) class I and MHC Class II proteins: conformational plasticity in antigen presentation","volume":"8","author":"Wieczorek","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nri3818","article-title":"The ins and outs of MHC class II-mediated antigen processing and presentation","volume":"15","author":"Roche","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib47","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev-immunol-051116-052450","article-title":"Unfinished business: evolution of the MHC and the adaptive immune system of jawed vertebrates","volume":"36","author":"Kaufman","year":"2018","journal-title":"Annu Rev. Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib48","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of MHC class I and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib49","article-title":"Variations in MHC class I antigen presentation and immunopeptidome selection pathways","volume":"9","author":"Zaitoua","year":"2020","journal-title":"F1000Res"},{"key":"10.1016\/j.phrs.2024.107168_bib50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/imr.12435","article-title":"Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications","volume":"272","author":"Afridi","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.phrs.2024.107168_bib51","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nrd2224","article-title":"More than one reason to rethink the use of peptides in vaccine design","volume":"6","author":"Purcell","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2024.107168_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051155","article-title":"MHC class i regulation: the origin perspective","volume":"12","author":"Sznarkowska","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2024.107168_bib53","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/bs.pbr.2019.10.006","article-title":"Innate and adaptive immune responses in Parkinson's disease","volume":"252","author":"Schonhoff","year":"2020","journal-title":"Prog. Brain Res"},{"key":"10.1016\/j.phrs.2024.107168_bib54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ni.2190","article-title":"How the TCR balances sensitivity and specificity for the recognition of self and pathogens","volume":"13","author":"Morris","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib55","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.4049\/jimmunol.1500792","article-title":"B cell-specific MHC class II deletion reveals multiple nonredundant roles for B cell antigen presentation in murine lupus","volume":"195","author":"Giles","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib56","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/imm.13114","article-title":"Cancer immune escape: MHC expression in primary tumours versus metastases","volume":"158","author":"Garrido","year":"2019","journal-title":"Immunology"},{"key":"10.1016\/j.phrs.2024.107168_bib57","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/s41388-019-1045-6","article-title":"MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt\/beta-catenin signaling pathway.","volume":"39","author":"Yang","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2024.107168_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000590","article-title":"Lack of the MHC class II chaperone H2-O causes susceptibility to autoimmune diseases","volume":"18","author":"Welsh","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.phrs.2024.107168_bib59","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s11064-012-0920-0","article-title":"The expression pattern of classical MHC class I molecules in the development of mouse central nervous system","volume":"38","author":"Liu","year":"2013","journal-title":"Neurochem Res"},{"key":"10.1016\/j.phrs.2024.107168_bib60","doi-asserted-by":"crossref","first-page":"22278","DOI":"10.1073\/pnas.0914064107","article-title":"MHC class I modulates NMDA receptor function and AMPA receptor trafficking","volume":"107","author":"Fourgeaud","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107168_bib61","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.tins.2012.08.001","article-title":"Major histocompatibility complex class I proteins in brain development and plasticity","volume":"35","author":"Elmer","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.phrs.2024.107168_bib62","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s11064-018-2676-7","article-title":"MHC class I molecules and pirb shape neuronal morphology by affecting the dendritic arborization of cortical neurons","volume":"44","author":"Shen","year":"2019","journal-title":"Neurochem Res"},{"key":"10.1016\/j.phrs.2024.107168_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.573208","article-title":"MiR34a Regulates Neuronal MHC class i molecules and promotes primary hippocampal neuron dendritic growth and branching","volume":"14","author":"Hu","year":"2020","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.phrs.2024.107168_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/srep24251","article-title":"MHC-class-II are expressed in a subpopulation of human neural stem cells in vitro in an IFNgamma-independent fashion and during development","volume":"6","author":"Vagaska","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107168_bib65","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fimmu.2019.00303","article-title":"Autoimmunity in Parkinson's disease: the role of alpha-synuclein-specific T cells","volume":"10","author":"Garretti","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib66","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40035-016-0063-3","article-title":"The biomarkers of immune dysregulation and inflammation response in Parkinson disease","volume":"5","author":"Chen","year":"2016","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.phrs.2024.107168_bib67","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1126\/science.aag2638","article-title":"Multifaceted interactions between adaptive immunity and the central nervous system","volume":"353","author":"Kipnis","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.phrs.2024.107168_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/science.abo7649","article-title":"Transforming the understanding of brain immunity","volume":"380","author":"Castellani","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.phrs.2024.107168_bib69","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1126\/science.abj8183","article-title":"Bespoke brain immunity","volume":"373","author":"Nguyen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.phrs.2024.107168_bib70","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","article-title":"Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-naive and drug-treated patients.","volume":"15","author":"Kustrimovic","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2024.107168_bib71","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12974-019-1606-1","article-title":"Regulatory impairment in untreated Parkinson's disease is not restricted to Tregs: other regulatory populations are also involved","volume":"16","author":"Alvarez-Luquin","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2024.107168_bib72","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001125","article-title":"Abnormal B-Cell and Tfh-cell profiles in patients with Parkinson Disease: a cross-sectional study","volume":"9","author":"Li","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.phrs.2024.107168_bib73","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbi.2022.01.005","article-title":"Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson's disease and cognition.","volume":"101","author":"Konstantin Nissen","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2024.107168_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.992505","article-title":"Single-cell RNA sequencing of CSF reveals neuroprotective RAC1(+) NK cells in Parkinson's disease.","volume":"13","author":"Guan","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib75","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2024.107168_bib76","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12974-020-01911-4","article-title":"T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an alpha-synuclein rat model of Parkinson's disease","volume":"17","author":"Subbarayan","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2024.107168_bib77","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1093\/brain\/awaa269","article-title":"CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease","volume":"143","author":"Galiano-Landeira","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2024.107168_bib78","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1038\/ncomms4633","article-title":"MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration","volume":"5","author":"Cebrian","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107168_bib79","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00401-004-0919-y","article-title":"Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains","volume":"109","author":"Imamura","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.phrs.2024.107168_bib80","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40478-017-0494-9","article-title":"alpha-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration","volume":"5","author":"Harms","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.phrs.2024.107168_bib81","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The Microbiota-gut-brain axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2024.107168_bib82","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41531-017-0010-8","article-title":"LRRK2 levels in immune cells are increased in Parkinson's disease","volume":"3","author":"Cook","year":"2017","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.phrs.2024.107168_bib83","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.brainres.2012.05.036","article-title":"Brain transcriptomic profiling in idiopathic and LRRK2-associated Parkinson's disease","volume":"1466","author":"Botta-Orfila","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.phrs.2024.107168_bib84","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1523\/JNEUROSCI.3621-17.2018","article-title":"Increased microglial activity, impaired adult hippocampal neurogenesis, and depressive-like behavior in microglial VPS35-depleted ice","volume":"38","author":"Appel","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107168_bib85","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3389\/fimmu.2020.00994","article-title":"Role of DJ-1 in Immune and Inflammatory Diseases","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib86","article-title":"PARK7\/DJ-1 in microglia: implications in Parkinson's disease and relevance as a therapeutic target","volume":"20","author":"Mogensen","year":"2023","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2024.107168_bib87","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neuroscience.2020.06.001","article-title":"Down-regulation of DJ-1 augments neuroinflammation via Nrf2\/Trx1\/NLRP3 Axis in MPTP-induced Parkinson's Disease mouse model","volume":"442","author":"Ji","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2024.107168_bib88","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/jamaneurol.2013.1274","article-title":"Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations","volume":"70","author":"Chahine","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.phrs.2024.107168_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33921-x","article-title":"Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease","volume":"8","author":"Atashrazm","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107168_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186881","article-title":"Metabolism of glycosphingolipids and their role in the pathophysiology of lysosomal storage disorders","volume":"21","author":"Ryckman","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107168_bib91","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-020-00408-1","article-title":"Glycosphingolipids and neuroinflammation in Parkinson's disease","volume":"15","author":"Belarbi","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.phrs.2024.107168_bib92","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/imr.12422","article-title":"Autophagy proteins in antigen processing for presentation on MHC molecules","volume":"272","author":"M\u00fcnz","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.phrs.2024.107168_bib93","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","article-title":"The link between the gene and parkinsonism","volume":"11","author":"Sidransky","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.phrs.2024.107168_bib94","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/15548627.2019.1603547","article-title":"Emerging views of mitophagy in immunity and autoimmune diseases","volume":"16","author":"Xu","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.phrs.2024.107168_bib95","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.it.2016.08.016","article-title":"Mitochondrial antigen presentation: a vacuolar path to autoimmunity in Parkinson's Disease","volume":"37","author":"Baden","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib96","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.cell.2016.05.039","article-title":"Parkinson's disease-related proteins PINK1 and parkin repress mitochondrial antigen presentation","volume":"166","author":"Matheoud","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2024.107168_bib97","first-page":"S13","article-title":"Immunogenetic determinants of Parkinson's Disease Etiology","volume":"12","author":"Kung","year":"2022","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.phrs.2024.107168_bib98","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molimm.2023.06.005","article-title":"Deficiency of Pink1 promotes the differentiation of Th1 cells","volume":"160","author":"Mei","year":"2023","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib99","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-019-1405-y","article-title":"Intestinal infection triggers Parkinson's disease-like symptoms in Pink1-\/- mice","volume":"571","author":"Matheoud","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107168_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577694","article-title":"PARKIN modifies peripheral immune response and increases neuroinflammation in active experimental autoimmune encephalomyelitis (EAE)","volume":"359","author":"Cossu","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phrs.2024.107168_bib101","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11481-019-09851-4","article-title":"Where is dopamine and how do immune cells see it?: Dopamine-mediated immune cell function in health and disease","volume":"15","author":"Matt","year":"2020","journal-title":"J. Neuroimmune Pharm."},{"key":"10.1016\/j.phrs.2024.107168_bib102","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.4103\/1673-5374.284976","article-title":"Dopamine: an immune transmitter","volume":"15","author":"Thomas Broome","year":"2020","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.phrs.2024.107168_bib103","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.phrs.2024.107168_bib104","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11481-019-09834-5","article-title":"Targeting the dopaminergic system in autoimmunity","volume":"15","author":"Vidal","year":"2020","journal-title":"J. Neuroimmune Pharm."},{"key":"10.1016\/j.phrs.2024.107168_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2022.102626","article-title":"Dopamine and norepinephrine are embracing their immune side and so should we","volume":"77","author":"Gaskill","year":"2022","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.phrs.2024.107168_bib106","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/jcp.25518","article-title":"Neurotransmitters: the critical modulators regulating gut-brain axis","volume":"232","author":"Mittal","year":"2017","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.phrs.2024.107168_bib107","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcmgh.2021.04.006","article-title":"The heteromeric complex formed by dopamine receptor D(5) and CCR9 leads the gut homing of CD4(+) T cells upon inflammation","volume":"12","author":"Osorio-Barrios","year":"2021","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2024.107168_bib108","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1124\/pharmrev.122.000618","article-title":"Dopamine, immunity, and disease","volume":"75","author":"Channer","year":"2023","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.phrs.2024.107168_bib109","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0165-5728(02)00280-1","article-title":"Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study","volume":"132","author":"McKenna","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phrs.2024.107168_bib110","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3389\/fimmu.2020.01869","article-title":"Critical neurotransmitters in the neuroimmune network","volume":"11","author":"Hodo","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib111","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.bbi.2009.10.015","article-title":"The immunoregulatory role of dopamine: an update","volume":"24","author":"Sarkar","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2024.107168_bib112","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature23013","article-title":"T(FH)-derived dopamine accelerates productive synapses in germinal centres.","volume":"547","author":"Papa","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107168_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577328","article-title":"Immunomodulatory effect and clinical outcome in Parkinson's disease patients on levodopa-pramipexole combo therapy: a two-year prospective study","volume":"347","author":"Espinosa-Cardenas","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phrs.2024.107168_bib114","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbi.2021.08.220","article-title":"Dopamine receptor D2 on CD4(+) T cells is protective against neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease","volume":"98","author":"Liu","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2024.107168_bib115","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.4049\/jimmunol.1502420","article-title":"Dopamine receptor D3 signaling on CD4+ T Cells Favors Th1- and Th17-mediated immunity","volume":"196","author":"Contreras","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib116","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.4049\/jimmunol.1203121","article-title":"Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease","volume":"190","author":"Gonzalez","year":"2013","journal-title":"J Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib117","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","article-title":"Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome","volume":"160","author":"Yan","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2024.107168_bib118","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature11748","article-title":"Suppression of neuroinflammation by astrocytic dopamine D2 receptors via alphaB-crystallin","volume":"494","author":"Shao","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107168_bib119","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbi.2018.03.020","article-title":"The dopamine transporter: an unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease","volume":"70","author":"Mackie","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2024.107168_bib120","doi-asserted-by":"crossref","DOI":"10.3390\/cells12020269","article-title":"Who knew? Dopamine transporter activity is critical in innate and adaptive immune responses","volume":"12","author":"Gopinath","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2024.107168_bib121","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1134\/S0006297918090122","article-title":"Immunogenetic factors of neurodegenerative diseases: the role of HLA Class II","volume":"83","author":"Aliseychik","year":"2018","journal-title":"Biochem. (Mosc."},{"key":"10.1016\/j.phrs.2024.107168_bib122","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41583-020-0263-9","article-title":"Immune cell regulation of glia during CNS injury and disease","volume":"21","author":"Greenhalgh","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2024.107168_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105028","article-title":"Microglia and astrocyte dysfunction in parkinson's disease","volume":"144","author":"Kam","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2024.107168_bib124","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13195-015-0139-9","article-title":"Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains","volume":"7","author":"Walker","year":"2015","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.phrs.2024.107168_bib125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094676","article-title":"The Contribution of microglia to neuroinflammation in Parkinson's Disease","volume":"22","author":"Badanjak","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107168_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.636139","article-title":"Genetic Defects and pro-inflammatory cytokines in Parkinson's Disease","volume":"12","author":"Magnusen","year":"2021","journal-title":"Front Neurol."},{"key":"10.1016\/j.phrs.2024.107168_bib127","doi-asserted-by":"crossref","first-page":"a009381","DOI":"10.1101\/cshperspect.a009381","article-title":"Inflammation and adaptive immunity in Parkinson's disease","volume":"2","author":"Mosley","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"10.1016\/j.phrs.2024.107168_bib128","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1084\/jem.20180794","article-title":"Microbiome-microglia connections via the gut-brain axis","volume":"216","author":"Abdel-Haq","year":"2019","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.phrs.2024.107168_bib129","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nature09944","article-title":"Enterotypes of the human gut microbiome","volume":"473","author":"Arumugam","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107168_bib130","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.4103\/1673-5374.262582","article-title":"Cross-talk between T-cells and gut-microbiota in neurodegenerative disorders","volume":"14","author":"Pacheco","year":"2019","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.phrs.2024.107168_bib131","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/imm.13270","article-title":"Why do intestinal epithelial cells express MHC class II?","volume":"162","author":"Heuberger","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.phrs.2024.107168_bib132","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.3389\/fimmu.2019.01970","article-title":"Human intestinal enteroids model MHC-II in the gut epithelium","volume":"10","author":"Wosen","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib133","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00476-21","article-title":"Quantifying the impact of human leukocyte antigen on the human gut microbiota","volume":"6","author":"Andeweg","year":"2021","journal-title":"mSphere"},{"key":"10.1016\/j.phrs.2024.107168_bib134","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/bpa.12886","article-title":"IL-1beta\/IL-1R1 signaling induced by intranasal lipopolysaccharide infusion regulates alpha-Synuclein pathology in the olfactory bulb, substantia nigra and striatum.","volume":"30","author":"Niu","year":"2020","journal-title":"Brain Pathol."},{"key":"10.1016\/j.phrs.2024.107168_bib135","first-page":"493","article-title":"The role of innate and adaptive immunity in Parkinson's disease","volume":"3","author":"Kannarkat","year":"2013","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.phrs.2024.107168_bib136","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12974-019-1628-8","article-title":"Midbrain microglia mediate a specific immunosuppressive response under inflammatory conditions","volume":"16","author":"Abellanas","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2024.107168_bib137","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/glia.22935","article-title":"Evidence for a role of adaptive immune response in the disease pathogenesis of the MPTP mouse model of Parkinson's disease","volume":"64","author":"Martin","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2024.107168_bib138","first-page":"S137","article-title":"Neuronal presentation of antigen and its possible role in Parkinson's Disease","volume":"12","author":"Hobson","year":"2022","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.phrs.2024.107168_bib139","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12974-020-01776-7","article-title":"Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson's disease brain","volume":"17","author":"Rostami","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2024.107168_bib140","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00109-018-1709-7","article-title":"Antigen-presenting cell diversity for T cell reactivation in central nervous system autoimmunity","volume":"96","author":"Waisman","year":"2018","journal-title":"J. Mol. Med (Berl. )"},{"key":"10.1016\/j.phrs.2024.107168_bib141","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","article-title":"Parkinson disease and the immune system - associations, mechanisms and therapeutics","volume":"16","author":"Tan","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2024.107168_bib142","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126517","article-title":"Alpha-Synuclein as a prominent actor in the inflammatory synaptopathy of Parkinson's Disease","volume":"22","author":"Cardinale","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107168_bib143","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.tins.2022.08.001","article-title":"How the immune system shapes neurodegenerative diseases","volume":"45","author":"Mason","year":"2022","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.phrs.2024.107168_bib144","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fnana.2014.00114","article-title":"Neuronal MHC-I expression and its implications in synaptic function, axonal regeneration and Parkinson's and other brain diseases","volume":"8","author":"Cebrian","year":"2014","journal-title":"Front Neuroanat."},{"key":"10.1016\/j.phrs.2024.107168_bib145","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00401-021-02268-5","article-title":"Periphery and brain, innate and adaptive immunity in Parkinson's disease","volume":"141","author":"Harms","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.phrs.2024.107168_bib146","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.4103\/1673-5374.313057","article-title":"Stress increases MHC-I expression in dopaminergic neurons and induces autoimmune activation in Parkinson's disease","volume":"16","author":"Wang","year":"2021","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.phrs.2024.107168_bib147","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/B978-0-12-819410-2.00023-0","article-title":"T cells, alpha-synuclein and Parkinson disease","volume":"184","author":"Garretti","year":"2022","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.phrs.2024.107168_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105771","article-title":"Immune-related biomarkers for Parkinson's disease","volume":"170","author":"Abdi","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2024.107168_bib149","article-title":"Exposure to the functional bacterial amyloid protein curli enhances alpha-synuclein aggregation in aged fischer 344 rats and caenorhabditis elegans","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107168_bib150","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson's Disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2024.107168_bib151","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1212\/WNL.0000000000003961","article-title":"Vagotomy and Parkinson disease: a Swedish register-based matched-cohort study","volume":"88","author":"Liu","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2024.107168_bib152","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar5280","article-title":"The vermiform appendix impacts the risk of developing Parkinson's disease","volume":"10","author":"Killinger","year":"2018","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.phrs.2024.107168_bib153","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001376","article-title":"Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons","volume":"3","author":"Benner","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2024.107168_bib154","first-page":"eabf7266","article-title":"CD4(+) T cells contribute to neurodegeneration in Lewy body dementia","author":"Gate","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.phrs.2024.107168_bib155","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12974-020-01888-0","article-title":"Neuroinflammation is associated with infiltration of T cells in Lewy body disease and alpha-synuclein transgenic models","volume":"17","author":"Iba","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2024.107168_bib156","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/awab103","article-title":"CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease","volume":"144","author":"Williams","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2024.107168_bib157","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1233870","article-title":"The role of the CD8+ T cell compartment in ageing and neurodegenerative disorders","volume":"14","author":"Terrabuio","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib158","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00281-022-00947-3","article-title":"The immunology of Parkinson's disease","volume":"44","author":"Zhu","year":"2022","journal-title":"Semin Immunopathol."},{"key":"10.1016\/j.phrs.2024.107168_bib159","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature22815","article-title":"T cells from patients with Parkinson's disease recognize alpha-synuclein peptides","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107168_bib160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.coi.2019.07.004","article-title":"Roles for the adaptive immune system in Parkinson's and Alzheimer's diseases","volume":"59","author":"Lindestam Arlehamn","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib161","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/s41467-020-15626-w","article-title":". alpha-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease","volume":"11","author":"Lindestam Arlehamn","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107168_bib162","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13092","article-title":"T-cell infiltration, contribution and regulation in the central nervous system post-traumatic injury","volume":"54","author":"Xu","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.phrs.2024.107168_bib163","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.tins.2023.07.005","article-title":"The systemic immune response in Parkinson's disease: focus on the peripheral immune component","volume":"46","author":"Lauritsen","year":"2023","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.phrs.2024.107168_bib164","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13022","article-title":"The role of innate immunity and inflammation in Parkinson s disease","volume":"93","author":"Oberg","year":"2021","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.phrs.2024.107168_bib165","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12974-016-0606-7","article-title":"Identification of a specific alpha-synuclein peptide (alpha-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons","volume":"13","author":"Wang","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2024.107168_bib166","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/glia.20532","article-title":"Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein","volume":"55","author":"Zhang","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2024.107168_bib167","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12974-018-1171-z","article-title":"Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration","volume":"15","author":"Duffy","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2024.107168_bib168","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1038\/s41467-021-26519-x","article-title":"Microglia-specific overexpression of alpha-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity","volume":"12","author":"Bido","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107168_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108895","article-title":"TNF-alpha and alpha-synuclein fibrils differently regulate human astrocyte immune reactivity and impair mitochondrial respiration","volume":"34","author":"Russ","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2024.107168_bib170","doi-asserted-by":"crossref","first-page":"9592","DOI":"10.1523\/JNEUROSCI.5610-12.2013","article-title":"MHCII is required for alpha-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration","volume":"33","author":"Harms","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107168_bib171","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12974-018-1286-2","article-title":"Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease","volume":"15","author":"Williams","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2024.107168_bib172","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2017.07.016","article-title":"Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to alpha-synuclein-induced dopaminergic neurodegeneration","volume":"106","author":"Jimenez-Ferrer","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2024.107168_bib173","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbi.2020.10.017","article-title":"The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease","volume":"91","author":"Jimenez-Ferrer","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2024.107168_bib174","doi-asserted-by":"crossref","DOI":"10.3390\/cells8101270","article-title":"Genomic diversity of the major histocompatibility complex in health and disease","volume":"8","author":"Kulski","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2024.107168_bib175","series-title":"Parkinson's Disease: Pathogenesis and Clinical Aspects. Brisbane","article-title":"Immunogenetics of Parkinson's Disease","author":"Jimenez-Ferrer","year":"2018"},{"key":"10.1016\/j.phrs.2024.107168_bib176","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1021\/acschemneuro.8b00373","article-title":"Gene dysfunction mediates immune response to dopaminergic degeneration in Parkinson's Disease","volume":"10","author":"Jiao","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.phrs.2024.107168_bib177","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1016\/j.neuron.2023.07.015","article-title":"Interaction of an alpha-synuclein epitope with HLA-DRB1( *)15:01 triggers enteric features in mice reminiscent of prodromal Parkinson's disease","volume":"111","author":"Garretti","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2024.107168_bib178","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1136\/jnnp.2008.162883","article-title":"Association of the human leucocyte antigen region with susceptibility to Parkinson's disease","volume":"81","author":"Saiki","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107168_bib179","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neulet.2011.05.245","article-title":"HLA rs3129882 variant in Chinese Han patients with late-onset sporadic Parkinson disease","volume":"501","author":"Guo","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2024.107168_bib180","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/ng.642","article-title":"Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease","volume":"42","author":"Hamza","year":"2010","journal-title":"Nat. Genet"},{"key":"10.1016\/j.phrs.2024.107168_bib181","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.ajhg.2013.10.009","article-title":"Association of Parkinson disease with structural and regulatory variants in the HLA region","volume":"93","author":"Wissemann","year":"2013","journal-title":"Am. J. Hum. Genet"},{"key":"10.1016\/j.phrs.2024.107168_bib182","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/mds.25035","article-title":"Association between Parkinson's disease and the HLA-DRB1 locus","volume":"27","author":"Ahmed","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.phrs.2024.107168_bib183","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/mds.28583","article-title":"Trans-ethnic fine-mapping of the major histocompatibility complex region linked to Parkinson's Disease","volume":"36","author":"Naito","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.phrs.2024.107168_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104760","article-title":"Immunotherapy for Parkinson's disease","volume":"137","author":"Schwab","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2024.107168_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104587","article-title":"Immunotherapy in Parkinson's disease: current status and future directions","volume":"132","author":"Chatterjee","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2024.107168_bib186","doi-asserted-by":"crossref","DOI":"10.3390\/cells11111732","article-title":"Alpha-synuclein aggregation pathway in parkinson's disease: current status and novel therapeutic approaches","volume":"11","author":"Vidovic","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2024.107168_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108843","article-title":"Progress of immunotherapy of anti-alpha-synuclein in Parkinson's disease","volume":"115","author":"Wang","year":"2019","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2024.107168_bib188","doi-asserted-by":"crossref","DOI":"10.3390\/cells8020105","article-title":"Novel immunotherapeutic approaches to target alpha-synuclein and related neuroinflammation in Parkinson's Disease","volume":"8","author":"Zella","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2024.107168_bib189","first-page":"S201","article-title":"Therapeutic strategies for immune transformation in Parkinson's Disease","volume":"12","author":"Saleh","year":"2022","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.phrs.2024.107168_bib190","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.intimp.2004.05.006","article-title":"Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease","volume":"4","author":"Kurkowska-Jastrzebska","year":"2004","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.phrs.2024.107168_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107269","article-title":"A bibenzyl compound 20C protects rats against 6-OHDA-induced damage by regulating adaptive immunity associated molecules","volume":"91","author":"Wang","year":"2021","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.phrs.2024.107168_bib192","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.4103\/1673-5374.357903","article-title":"Neuro faces of beneficial T cells: essential in brain, impaired in aging and neurological diseases, and activated functionally by neurotransmitters and neuropeptides","volume":"18","author":"Levite","year":"2023","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.phrs.2024.107168_bib193","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015237","article-title":"Alpha-synuclein-specific regulatory T cells ameliorate Parkinson's disease progression in mice","volume":"24","author":"Park","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107168_bib194","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41586-023-06300-4","article-title":"Co-transplantation of autologous T(reg) cells in a cell therapy for Parkinson's disease.","volume":"619","author":"Park","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107168_bib195","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1007\/s13311-020-00877-8","article-title":"Neuroprotective activities of long-acting granulocyte-macrophage colony-stimulating factor (mPDM608) in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated mice","volume":"17","author":"Olson","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.phrs.2024.107168_bib196","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3389\/fncel.2019.00421","article-title":"A synthetic agonist to vasoactive intestinal peptide receptor-2 induces regulatory T cell neuroprotective activities in models of Parkinson's disease","volume":"13","author":"Mosley","year":"2019","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.phrs.2024.107168_bib197","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/exnr.2000.7537","article-title":"Survival of intrastriatal xenografts of ventral mesencephalic dopamine neurons from MHC-deficient mice to adult rats","volume":"167","author":"Duan","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2024.107168_bib198","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jneuroim.2016.05.002","article-title":"RNAi-mediated silencing of HLA A2 suppressed acute rejection against human fibroblast xenografts in the striatum of 6-OHDA lesioned rats","volume":"297","author":"Liang","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phrs.2024.107168_bib199","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/mt.2013.59","article-title":"HLA engineering of human pluripotent stem cells","volume":"21","author":"Riolobos","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phrs.2024.107168_bib200","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69784-4","article-title":"Establishment of an experimental model for MHC homo-to-hetero transplantation","volume":"10","author":"Murata","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107168_bib201","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41467-017-00926-5","article-title":"MHC matching improves engraftment of iPSC-derived neurons in non-human primates","volume":"8","author":"Morizane","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107168_bib202","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41598-020-79726-9","article-title":"The TCR repertoire of alpha-synuclein-specific T cells in Parkinson's disease is surprisingly diverse","volume":"11","author":"Singhania","year":"2021","journal-title":"Sci. Rep."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824001129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824001129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T03:36:43Z","timestamp":1714275403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824001129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":202,"alternative-id":["S1043661824001129"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107168","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The major histocompatibility complex participates in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107168"}}